Dermatofibroma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Removing from Primary care |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dermatofibroma}} | {{Dermatofibroma}} | ||
{{CMG}}, {{AE}}{{Homa}} | |||
==Overview== | |||
There are no established measures for the [[secondary prevention]] of dermatofibroma. | |||
==Secondary Prevention== | |||
There are no established measures for the [[secondary prevention]] of dermatofibroma. | |||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{WH}} | |||
{{WS}} | |||
| |||
[[Category: | [[Category:Medicine]] | ||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Latest revision as of 21:18, 29 July 2020
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma secondary prevention |
|
Risk calculators and risk factors for Dermatofibroma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established measures for the secondary prevention of dermatofibroma.
Secondary Prevention
There are no established measures for the secondary prevention of dermatofibroma.
References